| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 10.96B | 10.96B | 11.60B | 12.14B | 10.70B | 8.82B | 
| Gross Profit | 6.52B | 6.52B | 6.97B | 7.25B | 6.47B | 5.29B | 
| EBITDA | 3.28B | 3.28B | 3.19B | 3.75B | 3.33B | 2.63B | 
| Net Income | 1.63B | 1.63B | 1.48B | 2.26B | 2.00B | 1.30B | 
| Balance Sheet | ||||||
| Total Assets | 37.08B | 37.08B | 39.19B | 37.68B | 36.01B | 32.15B | 
| Cash, Cash Equivalents and Short-Term Investments | 1.83B | 1.83B | 2.68B | 1.61B | 2.53B | 2.08B | 
| Total Debt | 12.59B | 12.59B | 13.62B | 11.87B | 11.17B | 9.60B | 
| Total Liabilities | 20.85B | 20.85B | 22.39B | 20.96B | 19.76B | 17.07B | 
| Stockholders Equity | 15.21B | 15.21B | 15.75B | 15.72B | 15.94B | 14.83B | 
| Cash Flow | ||||||
| Free Cash Flow | 435.00M | 0.00 | 954.00M | 1.33B | 1.79B | 1.57B | 
| Operating Cash Flow | 805.00M | 0.00 | 1.73B | 2.03B | 2.29B | 2.00B | 
| Investing Cash Flow | -506.00M | 0.00 | -676.00M | -1.73B | -1.20B | -486.00M | 
| Financing Cash Flow | -1.23B | 0.00 | -209.00M | -1.12B | -683.00M | -1.41B | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| 74 Outperform | €22.51B | 13.80 | 10.50% | 5.30% | -5.51% | 10.76% | |
| 72 Outperform | €557.96M | 11.89 | 7.74% | 2.20% | -5.79% | -25.29% | |
| 71 Outperform | €596.08M | 19.93 | 9.31% | 3.78% | -0.20% | 3.77% | |
| 64 Neutral | €2.56B | 20.34 | 6.42% | 3.00% | -17.54% | -35.36% | |
| 62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| 57 Neutral | €331.12M | 56.92 | 2.70% | ― | -5.42% | -43.44% | |
| 54 Neutral | €106.56M | 73.93 | 0.35% | 6.90% | -8.01% | -77.61% |